6 results about "Interferon tau" patented technology

1. The name of this design product: Insulin refrigerated cup. 2. Purpose of the product with this design: used for storing insulin, longevity hormones, interferon, eye drops, biological preparations, etc. 3. The key point of the design of this product lies in its shape. 4. The picture or photo that best illustrates the design points: three-dimensional picture.

1. Name of the design product: Refrigerated box (168). 2. Use of the design product: A refrigerated box for storing insulin, growth hormone, interferon, eye drops, biological agents, etc. 3. Design key points of the design product: Lies in the shape. 4. Picture or photo that best shows the design key points: Perspective view 1.

The present invention relates to the field of biomedicine, and more specifically, to the use of STING inhibitors in the preparation of medicaments for treating or preventing post-cardiac arrest syndrome. The present invention proposes that STING inhibitors, through their interventional effects, inhibit STING-mediated type I interferon activation, thereby alleviating brain damage in patients with post-cardiac arrest syndrome and improving their survival rate and prognosis.

A method for treating a subject having a diseased or atrophic state of fibrotic tissue, kidney disease and associated nerve endings, or for promoting tissue regeneration in muscle tissue is accomplished through exposing the tissue with a laser light having a wavelength of about 400 nm to about 700 nm, or more preferably having a wavelength of about 405 nm, about 532 nm, about 635 nm, or a combination thereof. Subsequent to exposure, mesenchymal stem cells can be administered to the subject. After the administration of mesenchymal stem cells, the tissue is further exposed to laser light having a wavelength of about 400 nm to about 700 nm, or a laser light having a single wavelength of about 400 nm to about 700 nm. The mesenchymal cells can be interferon gamma activated.

The present invention is directed to compositions for oral administration comprising two or more active ingredients selected from the group consisting of quercetin, metabolites, derivatives and salts and hydrates thereof, a kaempferol rutinoside and salts and hydrates thereof, indole-3-carbinol and derivatives and metabolites and salts and hydrates thereof and gallic acid and salts and hydrates thereof. The present invention is further directed to methods for treating dry eye disease, treating age-related macular degeneration, increasing Bruch's membrane stiffness, modulating expression of a gene selected from the group consisting of YAP, TAZ, integrin α5, integrin β5, interferon β1, interleukin-6, C-X-C motif chemokine ligand 1, C-X-C motif chemokine ligand 10, and combinations thereof, increasing adhesion of retinal pigment epithelium cells to a Bruch's membrane, and methods of modulating a secretory profile of senescent cells exhibiting the senescence-associated secretory phenotype comprising administering an effective amount of one or more active ingredients selected from the group consisting of kaempferol derivatives and salts thereof and hydrates thereof, quercetin metabolites, derivatives and salts and hydrates thereof, indole-3-carbinol and derivatives and metabolites and salts and hydrates thereof and gallic acid and salts and hydrates thereof to a subject in need thereof.

The invention discloses a stem cell exosome preparation for xerophthalmia or eye ulcer and a preparation method of the stem cell exosome preparation, and belongs to the technical field of biological medicine. The method comprises the following steps: carrying out low-intensity ultrasonic pulse treatment on the mesenchymal stem cells by adopting a pretreatment culture medium containing interferon-gamma and tumor necrosis factor-alpha; removing the pretreated culture medium, replacing the pretreated culture medium with a serum-free culture medium for continuous culture, collecting a culture solution, performing differential centrifugation, and collecting supernate; concentrating the supernate by using a tangential flow filtration system to obtain a concentrated solution; and loading the sample to a size exclusion chromatographic column for purification, and collecting an eluent to obtain the stem cell exosome. The invention discloses a stem cell exosome preparation for xerophthalmia or eye ulcer and a preparation method of the stem cell exosome preparation. A novel biological preparation which can be produced on a large scale and is safe and effective is provided for clinical treatment of xerophthalmia and corneal ulcer.